Chemical subgroup
L04AX – Andere Immunsuppressiva
6Decisions
7Patient groups
Added benefit by patient group
- Considerable1
- Non-quantifiable2
- Not proven4
Decisions, newest first
- 2024-01-18TecfideraDimethylfumaratNot proven
- 2019-12-05Imnovid PomalidomidNot proven
- 2018-11-22AlofiselDarvadstrocelNon-quantifiable
- 2016-03-17Imnovid PomalidomidConsiderable: 1 of 2 patient groupsNot proven: 1 of 2 patient groups
- 2014-10-16TecfideraDimethylfumaratNot proven
- 2012-03-15EsbrietPirfenidonNon-quantifiable
Data status: 2026-10-29